home / stock / pfe / pfe articles


PFE Articles, Pfizer Inc. - From 05/31/24

Stock Information

Company Name: Pfizer Inc.
Stock Symbol: PFE
Market: NYSE
Website: pfizer.com

Menu

PFE PFE Quote PFE Short PFE News PFE Articles PFE Message Board
Get PFE Alerts

News, Short Squeeze, Breakout and More Instantly...

How To Earn $500 A Month From Pfizer Stock | Benzinga

Shares of Pfizer Inc. (NYSE:PFE) closed higher during Thursday's session, with the company's stock adding around 10% over the past month....

Are Boomers Crashing The Economy Or Saving It? Why Investors Are Perplexed And What You Can Do To Prepare | Benzinga

The mass retirement of the boomer generation has been anticipated as one of the most impactful economic events of the 21st century. Economists are ...

With FDA Decision Date Approaching, Analyst Downgrades Sarepta On Balanced Risk And Reward | Benzinga

RBC Capital Markets has downgraded Sarepta Therapeutics Inc (NASDAQ:SRPT) as it weighs recent investor feedback, company commentary, and public s...

Sarepta Downgraded As FDA Decision Date Approaches, Shares Up 50% Over Last Six Months | Benzinga

RBC Capital Markets has downgraded Sarepta Therapeutics Inc (NASDAQ:SRPT) as it weighs recent investor feedback, company commentary, and ...

Jim Cramer: Celestica Makes A 'Comeback,' Sell This Movie Theater Stock, | Benzinga

On CNBC's “Mad Money Lightning Round,” Jim Cramer called Celestica Inc. (NYSE:CLS) “terrific” after the Toronto-based ...

Zantac Verdict: Jury Finds No Link To Colon Cancer In Initial Trial, GSK And Boehringer Prevail In First Zantac Cancer Lawsuit | Benzinga

A Chicago jury rejected an Illinois woman’s claim that the discontinued heartburn drug Zantac caused her colon cancer. This case is the first...

Pfizer Initiates Multi-Year Cost Reduction Plan Targeting $1.5B Savings By 2027 | Benzinga

Pfizer Inc. (NYSE:PFE) has launched a multi-year cost-cutting initiative aimed at saving approximately $1.5 billion by the end of 2027. What Happen...

Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb | Benzinga

Shares of vaccine producers' stocks are trading higher Wednesday on reports indicating disease experts predict a small rise in COVID-19 cases ...

GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims | Benzinga

GSK Plc (NYSE:GSK) has been reportedly sued by an independent Connecticut laboratory, Valisure, accusing the pharmaceutical giant of...

Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute | Benzinga

A Delaware federal jury has determined that AstraZeneca Plc (NASDAQ:AZN) must pay Pfizer Inc (NYSE:PFE) $107.5 million in ...

Previous 10 Next 10